Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

ASH 2017: Combination treatment with two targeted agents shows promise in previously treated CLL

ASH 2017: Combination treatment with two targeted agents shows promise in previously treated CLL

ASH 2017: Rapid responses, few adverse effects seen with targeted agent in Phase I trial in rare blood disorder

ASH 2017: Rapid responses, few adverse effects seen with targeted agent in Phase I trial in rare blood disorder

For leukaemia patients, transfusion needs may delay hospice care

For leukaemia patients, transfusion needs may delay hospice care

ASH 2017: Direct oral anticoagulant reduces recurrence of harmful clots in patients with cancer

ASH 2017: Direct oral anticoagulant reduces recurrence of harmful clots in patients with cancer

SABCS 2017: Two years of extended anastrazole therapy as effective as five

SABCS 2017: Two years of extended anastrazole therapy as effective as five

Diabetes drug metformin inhibits multidrug-resistant breast cancer

Diabetes drug metformin inhibits multidrug-resistant breast cancer

In multiple myeloma, high levels of enzyme ADAR1 are associated with reduced survival

In multiple myeloma, high levels of enzyme ADAR1 are associated with reduced survival

Scientists shed light on a tumour-suppressive protein in metastases

Scientists shed light on a tumour-suppressive protein in metastases

Shut-off switch for lymphoma

Shut-off switch for lymphoma

Blood test could help predict skin cancer’s return

Blood test could help predict skin cancer’s return

More from ecancer